Table 3.

Risk assessment of clinical parameters for advanced fibrosis

Variable	Fibrosis 0-2 (n = 88)	Fibrosis 3-4 (n = 15)	p	OR	95% CI
Age ≥ 50 years	39 (44.3%)	11 (73.3%)	0.038	3.455	1.021-11.694
BMI ≥ 28	58 (65.9%)	10 (66.7%)	0.954	1.034	0.324-3.302
DMt2	14 (15.9%)	5 (33.3%)	0.109	2.643	0.783-8.916
HOMA (<1.8)	32(46.4%)	7(70%)	0.193	2.698	0.644-11.306
AST/ALT ≥ 0,8	17 (19.3%)	13 (86.7%)	p < 0.001	27.147	5.592-131.974